Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 20, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 20, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/20/17 - KEVIN BRYANT: Culture change needed to fight opioid crisis
The opportunity to serve the Anderson community as an independent neighborhood pharmacist humbles me daily. Our access to a wide variety of medicines is the envy of most of the world, and it helps us lead happy and productive lives. But some of our loved ones succumb to a disease triggered by the very medicines that should help them.
8/20/17 - Landmark trial is using PET scans to diagnose Alzheimer's disease
By a News Reporter-Staff News Editor at VerticalNews Health& Science MAYWOOD, IL- Loyola Medicine is participating in a landmark $100 million study of the effectiveness of using PET scans to detect Alzheimer's disease. Alzheimer's disease has been linked to clumps of amyloid proteins, which block signals in the brain. The tracer drug has been app
8/20/17 - Mylan finalizes settlement over Medicaid payments for EpiPen
PITTSBURGH Generic drug giant Mylan announced Thursday it has finalized its settlement with the U.S. Department of Justice for overcharging Medicaid for the EpiPen. The settlement amount is $465 million, unchanged from when Mylan announced a preliminary deal in October that was criticized by lawmakers and others as not being harsh enough.
8/20/17 - New pharmacy designed to help treat people in their homes
Sometimes the healing process takes a while, but a new Grand Island- based business is designed to help patients heal in the comfort of their homes. Greater Nebraska Home Infusion, 2604 St. Patrick Ave., is owned by Rick and Cindy Lobeda. Lobeda has owned Midwest LTC Pharmacy, 3003 Frontage Road, for 10 years.
8/20/17 - Pharma Healthcare Newsletter - August 14 to August 18, 2017 [India Infoline News Service]
IPO Alert: Aster DM Healthcare refiles DRHP with SEBI. Aster DM Healthcare has refiled draft red herring prospectus with the market regulator, Securities and Exchange Board of India. Suven Life Sciences secures process patents in Europe, Japan and New Zealand.
8/20/17 - Regional GlaxoSmithKline chief reveals how new pharma is changing Gulf health care [Arab News (Saudi Arabia)]
What the critics call big pharma has had an image problem in recent years, and Andrew Miles, the executive in charge of the global health care company GlaxoSmithKline s business in the Gulf, thinks he knows how to resolve it. Choice of medication should be a clinical choice, rather than being based on some potential conflict of interest
8/20/17 - Researchers' Work from Bioinformatics Center Focuses on Life Science Research (THPdb: Database of FDA-approved peptide and protein therapeutics)
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Current study results on Life Science Research have been published. According to news reporting originating from Chandigarh, India, by NewsRx correspondents, research stated, "THPdb is a manually curated repository of Food and Drug Administration approved therapeutic peptides
8/20/17 - Scientists create stem cell therapy for lung fibrosis conditions
By a News Reporter-Staff News Editor at VerticalNews Health& Science CHAPEL HILL, NC- A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis, chronic obstructive pulmonary dis
8/20/17 - US pharmaceutical companies look to increase investments in Egypt [Egypt Independent]
During a meeting with Minister of Investment and International Cooperation, Sahar Nasr, on Friday, the representatives of the companies said that Egypt is the ideal market central investment in medicine, due to geographical location and large population. Executive director of Middle East affairs at the US Chamber of Commerce, Steve Lutes, said that
8/20/17 - USFDA completes inspection of Laurus Labs' API facilities [India Infoline News Service]
Laurus Labs, a leading research and development driven pharmaceuticals company, announced that it has completed the US Food and Drug Administration inspection of its API facilities in Units 1 and 3 at Parawada, Visakhapatnam, Andhra Pradesh with two observation which are only procedural in nature. Laurus Labs, a leading research and development dri
8/19/17 - "Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process (USPTO...
"Improved Factor Viii Preparations Suitable for Therapeutic Use and Processes to Obtain These" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors SCHMIDBAUER, Stefan; METZNER, Hubert; ROBBEL, Lars, filed on July 24, 2015, was made available online o
8/19/17 - AstraZeneca`s Lynparza gets additional US approval for ovarian cancer [Tehran Times (Iran)]
AstraZeneca and MSD have announced that the US Food and Drug Administration has granted approval for the PARP inhibitor, Lynparza. Sean Bohen, Executive Vice President, Global Medicines Development and Chief Medical Officer, AstraZeneca, said: Physicians have almost three years of clinical experience with Lynparza on the market and we are now pleas
8/19/17 - Attorney General Mills Announces Settlement With Maker of EpiPen for Overbilling Taxpayers
Maine Attorney General Janet T. Mills issued the following news release:. Attorney General Janet T. Mills announced today that Maine has agreed in principle to join the United States and other States to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.. Mylan Specialty is a Delaware limited partnership with
8/19/17 - Attorney General Shapiro Announces Mylan Pharmaceuticals to Pay Pennsylvania $8.3 Million in Restitution Over EpiPen Scam
Pennsylvania Attorney General Josh Shapiro issued the following news release:. Attorney General Josh Shapiro announced that Pennsylvania, along with the U.S. Justice Department, has finalized a settlement with the drug manufacturer Mylan Inc., resolving claims that it overcharged taxpayers for its EpiPen emergency allergy treatment.
8/19/17 - Biotech firm Destiny Pharma to float on Aim with drug that targets MRSA-type infections [Arab News (Saudi Arabia)]
The firm, whose chairman is City veteran Sir Nigel Rudd, the former chairman of Heathrow, will become only the second biotech company to float on the London stock market this year. The company is yet to finalise exactly how much it wants to raise through the float, but told The Telegraph it would be more than 10 m. It will initially target the US m
8/19/17 - Blood and Organ Bank Market Research Report by Geographical Analysis and Forecast to 2023
Transparency Market Research Report Added "Blood and Organ Bank Market" to its database.Albany, NY 08/18/2017 Blood transfusion and Organ transplant is done to save the life of an individual or to improve patient's health. According to the World Health Organization, out of 108 million blood donations done globally, 50% of the blood donations
8/19/17 - Cancer Research UK and Newcastle University extend drug discovery partnership with Astex [Syrian Arab News Agency]
Cancer Research UK and Newcastle University have extended their strategic drug discovery alliance with Astex Pharmaceuticals for three years. The scientists at the Cancer Research UK Drug Discovery Programme at the Northern Institute for Cancer Research, Newcastle University, will work together to discover and develop new cancer drugs and associate
8/19/17 - Citius Pharmaceuticals, Inc. Prices $6,800,000 Public Offering And Listing On The Nasdaq Capital Market
By a News Reporter-Staff News Editor at Investment Weekly News CITIUS PHARMACEUTICALS, INC., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced the pricing of an underwritten public offering of 1,648,484 shares of its common stock and warrants to purchase up to an aggregate of 1,648,484
8/19/17 - Delaware Medicaid Program to Be Reimbursed Almost $900K for Overcharges on EpiPens
Delaware Attorney General Matthew Denn issued the following news release:. The Medicaid Fraud Control Unit of the Delaware Department of Justice will join the United States and other states to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P.. Mylan Specialty owns the exclusive rights to sell EpiPen in the
8/19/17 - Emergency Veterinary Services Market 2024 Overview, Competitive Analysis and Development by Companies
Albany, NY 08/18/2017 Emergency Veterinary Services Market: Overview Veterinary medicine is a branch of science that is related with treatment, diagnostic, prevention of disease, illness, injury or disorders in animals. The scope of veterinary medicines is vast and covers wide range of diseased conditions that can affect different animal spec
8/19/17 - FDA grants two orphan drug designations for HCC [Sudan Tribune]
The U.S. Food and Drugs Administration has granted two orphan drug designations for T cell therapy products for the treatment of hepatocellular carcinoma. The FDA Orphan drug designations are granted to drugs and biologics intended for rare diseases that affect fewer than 200,000 people in the U.S, and provides incentives that may include tax credi
8/19/17 - FDA May Limit `Risk Info` in Direct-to-Consumer TV Drug Ads [Times of Oman]
But a new approach being considered could trim those lists to feature only the most serious and potentially fatal side effects, the FDA said Friday. To come to the best solution, the FDA is asking consumers, doctors and others to comment on which risk information is most helpful in TV and other broadcast ads. Nachum Katlowitz, director of urology a
8/19/17 - Government seeks caps on drug trade margins [Tehran Times (Iran)]
The government plans to cap trade margins to make drugs cheaper, replace brand names with salt names for generic drugs, clamp down on unfair marketing practices and boost local manufacturing to reduce dependence on imports, according to government`s draft national pharmaceutical policy. The draft, prepared by the pharmaceuticals department, also su
8/19/17 - Gwq Generic Tender (tacrolimus-aliud). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement regarding products with the active ingredient tacrolimus of the manufacturer ALIUD PHARMA GmbH. Time-limit for receipt of tenders or requests to participate: Date 15/08/2017 Local time 1000 IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected
8/19/17 - Gwq Generic Tender (tacrolimus-astellas). [TendersInfo (India)]
Contract notice: Gwq generic tender. Conclusion of a generic agreement regarding products with the active ingredient Tacrolimus from the manufacturer Astellas Pharma GmbH. Time limit for receipt of tenders or requests to participate: Date: 15/08/2017 Local time: 10:00 Major organization: GWQ SERVICEPLUS AG Address: Tersteegenstr. 28 Dsseldorf 40476
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415